Blog

We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Epirubicin.

We talked to Fiona Semple, Senior Post Doctoral Fellow, to find out more about the pioneering research project Make 2nds Count is funding with the Edinburgh Cancer Research Centre. Tell us about your role at the University of Edinburgh’s Breast Cancer Translational Research Group?

As part of our series looking at different chemotherapy treatments for secondary breast cancer, Terri Read shares her experience of Nab Paclitaxel (Abraxane) this week. When were you diagnosed with secondary breast cancer?

Thank you to Erin & the MyTomorrow's team for taking the time to talk to Claire about our work with secondary breast cancer patients. 

Find out more about the work of MyTomorrows here 

SECONDARY BREAST CANCER AWARENESS SHOULD BE A 365 DAY-A-YEAR CAMPAIGN Vital education needed for the forgotten cancer marked on 13th October each year Woeful ignorance of secondary breast cancer requires more than just a single awareness day today (October 13) to educate the public about this forgotten form of the disease. Charity Make 2nds Count which is leading a campaign to highlight secondary breast cancer, a disease currently killing 1000 women a month in the UK, says it needs to be a year-round initiative to prevent lives being destroyed.

We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Nab Paclitaxel.

I had my secondary diagnosis confirmed in 2016 straight after my primary treatment ended so I went from one massive hurdle straight into another one. No real time to breathe and ‘enjoy the moment’.

Two-fifths of UK population are unaware of the condition killing 1,000 women and men every month Astonishingly, just under two-fifths of the adult population in the UK are ignorant about secondary breast cancer, a new survey shows. The disease killed former Girls Aloud singer Sarah Harding last month (Sept) yet according to a YouGov poll just three weeks later, 38% of those questioned say they don’t know what secondary breast cancer is.

As part of our series looking at different chemotherapy treatments for secondary breast cancer, Angela Brant-Segarceanu shares her experience of Paclitaxel (Taxol) this week. When were you diagnosed with secondary breast cancer?

When there is talk about breast cancer, often sadly when someone well known passes away, it’s about primary breast cancer. The media focuses on stories of survival, remission and the well known signs and symptoms such as a lump.

We are looking at different types of chemotherapy - how you take it and possible side-effects - and then hearing from a patient about their experience. This week it’s Paclitaxel.

This week one of our 2nds Together community talks about her experience of being on vinorelbine, also known by the brand navelbine. When were you diagnosed?

On the 2nd of each month we talk about the signs and symptoms of secondary breast cancer. Diagnosing secondary breast cancer isn’t easy.

We are taking a look at the different types of chemotherapy drugs that can be used to treat secondary breast cancer and this week it’s Vinorelbine. What is Vinorelbine?

We are taking a look at different chemotherapy treatments for secondary breast cancer and then a patient shares their experience. This week Liz Gluckman talks about Docetaxel.